Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging

Journal Article · Sat Dec 01 00:00:00 EST 1990 · Clinical Nuclear Medicine; (USA)

DOI:https://doi.org/10.1097/00003072-199012000-00009· OSTI ID:6059670

Kuwabara, Y; Ichiya, Y; Otsuka, M; Tahara, T; Fukumura, T; Gunasekera, R; Masuda, K ^[1]

---

1. Kyushu Univ., Fukuoka (Japan)

This report discusses the clinical significance of bilateral parietal abnormalities on I-123 IMP SPECT imaging in 158 patients with cerebral disorders. This pattern was seen in 15 out of 21 patients with Alzheimer's disease; it was also seen in 4 out of 5 patients with Parkinson's disease with dementia, in 3 out of 17 patients with vascular dementia, in 1 out of 36 patients with cerebral infarction without dementia, in 1 out of 2 patients with hypoglycemia, and in 1 out of 2 patients with CO intoxication. Detection of bilateral parietal abnormalities is a useful finding in the diagnosis of Alzheimer's disease, but one should keep in mind that other cerebral disorders may also show a similar pattern with I-123 IMP SPECT imaging.

• OSTI ID: 6059670
• Journal Information: Clinical Nuclear Medicine; (USA), Vol. 15:12; ISSN 0363-9762
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BRAIN
SCINTISCANNING
CARBON MONOXIDE
TOXICITY
NERVOUS SYSTEM DISEASES
DIAGNOSIS
VASCULAR DISEASES
IODINE 123
PATIENTS
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
BETA DECAY RADIOISOTOPES
BODY
CARBON COMPOUNDS
CARBON OXIDES
CENTRAL NERVOUS SYSTEM
CHALCOGENIDES
COMPUTERIZED TOMOGRAPHY
COUNTING TECHNIQUES
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NUCLEI
ODD-EVEN NUCLEI
ORGANS
OXIDES
OXYGEN COMPOUNDS
RADIOISOTOPE SCANNING
RADIOISOTOPES
TOMOGRAPHY
550601* - Medicine- Unsealed Radionuclides in Diagnostics
560300 - Chemicals Metabolism & Toxicology